Michael Gotthardt at the Max Delbrück Center and collaborators are developing a drug to treat a common type of heart failure characterized by impaired cardiac filling. In a recent study, his group and ...
For the first time, scientists have succeeded in artificially mimicking the ion signaling of heart muscle cells. To succeed, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results